NK-CELL LYMPHOMA, UNCLASSIFIABLE

Clinical trials for NK-CELL LYMPHOMA, UNCLASSIFIABLE explained in plain language.

Never miss a new study

Get alerted when new NK-CELL LYMPHOMA, UNCLASSIFIABLE trials appear

Sign up with your email to follow new studies for NK-CELL LYMPHOMA, UNCLASSIFIABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Virus + drug combo tested for Tough-to-Treat skin cancers

Disease control Ongoing

This study is testing a two-part treatment for patients with advanced skin cancers or rare lymphomas that have not responded to other therapies. First, a modified virus is injected directly into tumors to help the immune system recognize cancer. Then, an immunotherapy drug is giv…

Matched conditions: NK-CELL LYMPHOMA, UNCLASSIFIABLE

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

NK-CELL LYMPHOMA, UNCLASSIFIABLE

Get alerted when new NK-CELL LYMPHOMA, UNCLASSIFIABLE trials appear

Virus + drug combo tested for Tough-to-Treat skin cancers